2020
DOI: 10.1590/1806-9282.66.6.778
|View full text |Cite
|
Sign up to set email alerts
|

Identification of key genes for type 1 diabetes mellitus by network-based guilt by association

Abstract: SUMMARY OBJECTIVE This study aimed to propose a co-expression-network (CEN) based gene functional inference by extending the “Guilt by Association” (GBA) principle to predict candidate gene functions for type 1 diabetes mellitus (T1DM). METHODS Firstly, transcriptome data of T1DM were retrieved from the genomics data repository for differentially expressed gene (DEGs) analysis, and a weighted differential CEN was generated. The area under the receiver operating characteristics curve (AUC) was chosen to det… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
(12 reference statements)
0
1
0
Order By: Relevance
“…Recently, several genes have been identified as having a potential diagnostic and prognostic value in DM and related complications such as diabetic nephropathy and diabetic cardiomyopathy. [12][13][14] In the realm of DR, various genes were also found to be potential candidates for DR diagnosis and progression. For instance, Li et al found that angiogenesis growth factors VEGFC, ANGPT1, ANGPT2, and EFNB2 were upregulated in DR patients, presenting their potentials as biomarkers for DR diagnosis and treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, several genes have been identified as having a potential diagnostic and prognostic value in DM and related complications such as diabetic nephropathy and diabetic cardiomyopathy. [12][13][14] In the realm of DR, various genes were also found to be potential candidates for DR diagnosis and progression. For instance, Li et al found that angiogenesis growth factors VEGFC, ANGPT1, ANGPT2, and EFNB2 were upregulated in DR patients, presenting their potentials as biomarkers for DR diagnosis and treatment.…”
Section: Introductionmentioning
confidence: 99%